Vimarsana
Biggest News Aggregation in the World

Andreas Wicki News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andreas Wicki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andreas Wicki Today - Breaking & Trending Today

HBM Healthcare Investments : Short Report 2023/2024 - Vimarsana News

HBM Healthcare Investments : Short Report 2023/2024

ANNUAL REPORT 2023/2024 SHORT REPORT About HBM Healthcare Investments HBM Healthcare Investments actively...

HBM Healthcare Investments activates share buyback programme - Vimarsana News

HBM Healthcare Investments activates share buyback programme

16.10.2023 - HBM Healthcare Investments AG / Key word(s): Share Buyback HBM Healthcare Investments activates share buyback programme 16-Oct-2023 / 06:40 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the ...

HBM Healthcare Investments announces the return of Dr Andreas Wicki; new investment of USD 12 million in ArriVent Biopharma - Vimarsana News

HBM Healthcare Investments announces the return of Dr Andreas Wicki; new investment of USD 12 million in ArriVent Biopharma

HBM Healthcare Investments AG / Key word: Personnel HBM Healthcare Investments announces the return of Dr Andreas Wicki; new investment of USD 12 million in ArriVent Biopharma 28-March-2023... | March 28, 2023

HBM Healthcare Investments informs about a temporary change in the Executive Board - Vimarsana News

HBM Healthcare Investments informs about a temporary change in the Executive Board

30.01.2023 - HBM Healthcare Investments AG / Key word(s): Personnel HBM Healthcare Investments informs about a temporary change in the Executive Board 30-Jan-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely ...

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Expected to Announce Quarterly Sales of $99.35 Million - Vimarsana News

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Expected to Announce Quarterly Sales of $99.35 Million

Brokerages expect Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) to report $99.35 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Harmony Biosciences’ earnings. The highest sales estimate is $100.50 million and the lowest is $96.88 million. Harmony Biosciences posted sales of $73.82 million in the […]